- 25 July 2011
- book chapter
- Published by Springer Nature
- p. 507-524
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsAnnals of the Rheumatic Diseases, 2010
- Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risksNeurological Sciences, 2009
- Current treatments of chronic immune‐mediated demyelinating polyneuropathiesMuscle & Nerve, 2009
- Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritisRheumatology, 2007
- Mycophenolate mofetil in solid-organ transplantationExpert Opinion on Pharmacotherapy, 2003
- Pharmacokinetics and Pharmacodynamics of Methotrexate in Non-Neoplastic DiseasesClinical Pharmacokinetics, 2003
- Cellular and Clinical Pharmacology of FludarabineClinical Pharmacokinetics, 2002
- Effect of mycophenolate mofetil on nitric oxide production and inducible nitric oxide synthase gene expression during renal ischaemia‐reperfusion injuryNephrology Dialysis Transplantation, 2001
- Mycophenolate mofetil, Cellcept®, a new immunosuppressive drug with great potential in internal medicineThe Netherlands Journal of Medicine, 2000
- Metabolism and Pharmacokinetics of OxazaphosphorinesClinical Pharmacokinetics, 2000